Operating Margin ExpansionThe strong performance of the medical device distribution business in Eastern Europe continues to support operating margin expansion, which reached 12.7%.
Revenue GrowthSvas Biosana delivered a solid 1Q 2025 with revenues of €32.7m (+14.3% YoY, +6.6% standalone), driven by recent acquisitions and strong momentum in the Balkans.
Strategic ExpansionSvas Biosana strengthens its positioning in the distribution of medical devices to public healthcare institutions by acquiring 51% of Mehos Srl, marking a new step in the company’s external growth strategy.